Aileron Therapeutics (ALRN) Q3 2024 Earnings

20AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-0.86
-0.62
-0.38
-0.14

Details

Expected EPS
-0.3056
Actual EPS
-0.45
Surprise EPS
-0.14
Surprise Percent
+47.25%

Description

Aileron Therapeutics (ALRN) has reported earnings of -0.45 per share for Q3 2024.

0 Comments

Share your thoughts